- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chemotherapy-induced neutropenia
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Pegfilgrastim – March 2020
Pegfilgrastim: Injection 6 mg in 0.6 ml single use pre-filled syringe; Pelgraz®
Last updated
3 July 2020